Eli Lilly launched a 75-second TV commercial called “Change” in November 2024 to promote the company’s GLP-1 obesity drug Zepbound (tirzepatide).
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,